Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewisa and sialyl-lewisx antigens in colorectal adenocarcinoma

Histopathology

Volumn 40, Issue 5, 2002, Pages 440-449

  Baldus, S E ^a   Monig S P ^a   Hanisch, F G ^a   Zirbes, T K ^a   Flucke, U ^a   Oelert, S ^a   Zilkens, G ^a   Madejczik, B ^a   Thiele, J ^a   Schneider, P M ^a   Holscher A H ^a   Dienes, H P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Colorectal carcinoma; Epithelial mucin; Lewis antigens; Monoclonal antibody; MUC1; Prognosis; Tumour associated antigen

Indexed keywords

MUCIN 1; MUCIN 2;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METHODOLOGY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-15-3 ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GANGLIOSIDES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCINS; NEOPLASM STAGING; OLIGOSACCHARIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 18444395585     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01389.x     Document Type: Article

References (43)

1. Mucin glycoproteins in neoplasia
2. MUC1 and cancer
3. Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia
4. MUC1: The polymorphic appearance of a human mucin
5. Cancer-associated MUC1 inhibits human T-cell proliferation, which is reversible by IL-2
6. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components
7. The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha6 beta4 mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction
8. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A
9. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium
10. Differential colon cancer cell adhesion to E-, P-, and L-selectin: Role of mucin-type glycoproteins
11. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line
12. Involvement of carbohydrate antigen sialyl Lewis (x) in colorectal cancer metastasis
13. Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine
14. Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon
15. Heterogeneity of mucin gene expression in normal and neoplastic tissues
16. Significance of MUC1 and MUC2 mucin expression in colorectal cancer
17. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, sialosyl-Tn) in benign and malignant lesions of colonic epithelium: Apolar localization corresponds to malignant transformation
18. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms
19. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma
20. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer
21. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation and angiogenesis at the deepest invasive portion of colorectal cancer
22. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas
23. Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope, as defined by monoclonal antibody FW6, is a marker of the colorectal adenoma-carcinoma sequence
24. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study
25. Gastrointestinal cancer-associated antigen in immunoperoxidase assay
26. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: Liver colonization and adhesion to vascular endothelial cells
27. Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length
28. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinomas
29. Expression of sialyl Lewis (a) as a new prognostic factor for patients with advanced colorectal carcinoma
30. Expression of Lewisa, sialyl Lewisa, Lewisx, and sialyl Lewisx antigens as prognostic factors in patients with colorectal cancer
31. x expression
32. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines
33. x-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer
34. Structures of the major oligosaccharides from a human rectal carcinoma glycoprotein
35. Alterations of O-glycan biosynthesis in human colon cancer tissues
36. Glycosylation patterns of mucins in colonic disease
37. Synthesis of O-glycan core 3: Characterization of UDP-GlcNAc: GalNAc-R beta3-N-acetylglucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines
38. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma
39. Inhibition of liver metastases from neuraminidase-treated Colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody
40. Survival in early breast cancer patients is favourably influenced by a natural humoral response to polymorphic epithelial mucin (MUC1)
41. Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy
42. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1
43. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion